Doug Ingle

Doug Ingle

Ask VT AI
View News Summary
  • Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
  • BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.
  • Chiefs' star left tackle Josh Simmons away from team, expected to return mid-November
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Roche raises profit forecast, plans major U.S. investment amid ongoing drug pricing talks.
  • BridgeBio reports positive Phase 3 results for two late-stage candidates, encaleret and BBP-418, driving a sharp rally in the company's shares.
  • Chiefs' star left tackle Josh Simmons away from team, expected to return mid-November
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Doug Ingle